BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Mao SY, Zhu WY. Impact of tiny miRNAs on cancers. World J Gastroenterol 2007; 13(4): 497-502 [PMID: 17278213 DOI: 10.3748/wjg.v13.i4.497] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Xu J, Xu J, Liu X, Jiang J. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Cell Death Discov 2022;8:287. [PMID: 35697671 DOI: 10.1038/s41420-022-01061-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Avvari S, Prasad D, Khan IA. Role of MicroRNAs in Cell Growth Proliferation and Tumorigenesis. Role of MicroRNAs in Cancers 2022. [DOI: 10.1007/978-981-16-9186-7_3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wu X, Kong C, Wu Y. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis. Bioengineered 2021;12:9046-57. [PMID: 34657558 DOI: 10.1080/21655979.2021.1993715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Osei E, Swanson S, Francis R. Review of novel liquid-based biomarkers for prostate cancer: towards personalised and targeted medicine. J Radiother Pract 2021. [DOI: 10.1017/s1460396921000248] [Reference Citation Analysis]
5 Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Lungulescu C, Scripcariu DV, Stolniceanu CR, Konsoulova-Kirova AA, Grigorescu C, Stefanescu C, Volovat CC, Augustin I. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Front Oncol 2020;10:526850. [PMID: 33330019 DOI: 10.3389/fonc.2020.526850] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 19.0] [Reference Citation Analysis]
6 Huang L, Deng FY, Lei SF. Global correlation analysis for miRNA and protein expression profiles in human peripheral blood mononuclear cells. Mol Biol Rep 2020;47:5295-304. [PMID: 32613399 DOI: 10.1007/s11033-020-05608-y] [Reference Citation Analysis]
7 Hanafi AR, Jayusman AM, Alfasunu S, Sadewa AH, Pramono D, Heriyanto DS, Haryana SM. [Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia]. Zhongguo Fei Ai Za Zhi 2020;23:321-32. [PMID: 32283582 DOI: 10.3779/j.issn.1009-3419.2020.104.02] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Bhat AA, Younes SN, Raza SS, Zarif L, Nisar S, Ahmed I, Mir R, Kumar S, Sharawat SK, Hashem S, Elfaki I, Kulinski M, Kuttikrishnan S, Prabhu KS, Khan AQ, Yadav SK, El-Rifai W, Zargar MA, Zayed H, Haris M, Uddin S. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Mol Cancer 2020;19:57. [PMID: 32164715 DOI: 10.1186/s12943-020-01175-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
9 Konstantinidis AΟ, Pardali D, Adamama-Moraitou KK, Gazouli M, Dovas CI, Legaki E, Brellou GD, Savvas I, Jergens AE, Rallis TS, Allenspach K. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Vet Res 2020;16:69. [PMID: 32087719 DOI: 10.1186/s12917-020-02287-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
10 Alzahem T, Alsarhani W, Albahlal A, Abu Safieh L, Aldahmash S. History and Genetics of Retinoblastoma. Retinoblastoma - Past, Present and Future 2019. [DOI: 10.5772/intechopen.89035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Fadaka AO, Pretorius A, Klein A. Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico Approach. Int J Mol Sci 2019;20:E5190. [PMID: 31635135 DOI: 10.3390/ijms20205190] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Luan Z, Liu B, Shi L. Angiotensin II-induced micro RNA-21 culprit for non-small-cell lung adenocarcinoma. Drug Dev Res 2019;80:1031-9. [PMID: 31823412 DOI: 10.1002/ddr.21597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Liu S, Feng S, Luo D. Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome. Int Urogynecol J 2019;30:1487-95. [PMID: 30456462 DOI: 10.1007/s00192-018-3817-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Oduor CI, Kaymaz Y, Chelimo K, Otieno JA, Ong'echa JM, Moormann AM, Bailey JA. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma. BMC Cancer 2017;17:761. [PMID: 29132323 DOI: 10.1186/s12885-017-3711-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
15 Srivastava S, Singh S, Fatima N, Mittal B, Srivastava AN. Pre-microRNA Gene Polymorphisms and Risk of Cervical Squamous Cell Carcinoma. J Clin Diagn Res 2017;11:GC01-4. [PMID: 29207732 DOI: 10.7860/JCDR/2017/25361.10543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Fu Y, Chen T, Wang G, Gu T, Xie C, Huang J, Li X, Best S, Han G. Production of a fluorescence resonance energy transfer (FRET) biosensor membrane for microRNA detection. J Mater Chem B 2017;5:7133-9. [PMID: 32263904 DOI: 10.1039/c7tb01399j] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
17 Yuan Q, Cao G, Li J, Zhang Y, Yang W. MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signaling. Gene 2017;628:48-55. [PMID: 28710032 DOI: 10.1016/j.gene.2017.07.031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
18 Ioniţă M, Vlăsceanu GM, Watzlawek AA, Voicu SI, Burns JS, Iovu H. Graphene and functionalized graphene: Extraordinary prospects for nanobiocomposite materials. Composites Part B: Engineering 2017;121:34-57. [DOI: 10.1016/j.compositesb.2017.03.031] [Cited by in Crossref: 107] [Cited by in F6Publishing: 110] [Article Influence: 21.4] [Reference Citation Analysis]
19 Pekow J, Meckel K, Dougherty U, Huang Y, Chen X, Almoghrabi A, Mustafi R, Ayaloglu-Butun F, Deng Z, Haider HI, Hart J, Rubin DT, Kwon JH, Bissonnette M. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clin Cancer Res 2017;23:5281-91. [PMID: 28600480 DOI: 10.1158/1078-0432.CCR-17-0171] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 10.4] [Reference Citation Analysis]
20 Wang L, Yao J, Sun H, He K, Tong D, Song T, Huang C. MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A. Oncol Lett 2017;13:329-38. [PMID: 28123563 DOI: 10.3892/ol.2016.5423] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
21 Mahdian-Shakib A, Dorostkar R, Tat M, Hashemzadeh MS, Saidi N. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer. Biomed Pharmacother 2016;84:592-600. [PMID: 27694003 DOI: 10.1016/j.biopha.2016.09.087] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 6.8] [Reference Citation Analysis]
22 Pal MK, Jaiswar SP, Dwivedi VN, Tripathi AK, Dwivedi A, Sankhwar P. MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer. Cancer Biol Med 2015;12:328-41. [PMID: 26779370 DOI: 10.7497/j.issn.2095-3941.2015.0024] [Cited by in F6Publishing: 52] [Reference Citation Analysis]
23 Yang Y, Chang S, Zhao Z, Hou NI, He K, Wang X, Gao L, Wang L, Cai D, Guo BO, Tong D, Song T, Huang C. MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3. Oncol Lett 2015;10:3779-84. [PMID: 26788207 DOI: 10.3892/ol.2015.3745] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
24 Goudarzi PK, Taheriazam A, Asghari S, Jamshidi M, Shakeri M, Yahaghi E, Mirghasemi A. Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcoma. Tumour Biol 2016;37:5775-9. [PMID: 26385770 DOI: 10.1007/s13277-015-4090-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Gupta S, Verma S, Mantri S, Berman NE, Sandhir R. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders. Drug Dev Res 2015;76:397-418. [PMID: 26359796 DOI: 10.1002/ddr.21277] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
26 Dadpay M, Zarea M, Rabati RG, Rezakhaniha B, Barari B, Behnod V, Ziari K. RETRACTED ARTICLE: Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosis. Tumour Biol 2015. [PMID: 26289847 DOI: 10.1007/s13277-015-3905-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Sadeghian Y, Kamyabi-Moghaddam Z, Nodushan SM, Khoshbakht S, Pedram B, Yahaghi E, Mokarizadeh A, Mohebbi M. RETRACTED ARTICLE: Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma. Tumour Biol 2015. [PMID: 26209296 DOI: 10.1007/s13277-015-3799-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
28 Hiyoshi Y, Schetter AJ, Okayama H, Inamura K, Anami K, Nguyen GH, Horikawa I, Hawkes JE, Bowman ED, Leung SY. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer. PLoS One. 2015;10:e0124899. [PMID: 25894979 DOI: 10.1371/journal.pone.0124899] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
29 Pekow J, Meckel K, Dougherty U, Butun F, Mustafi R, Lim J, Crofton C, Chen X, Joseph L, Bissonnette M. Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon. Am J Physiol Gastrointest Liver Physiol. 2015;308:G179-G187. [PMID: 25477374 DOI: 10.1152/ajpgi.00208.2014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
30 Ishiguro H, Kimura M, Takeyama H. Role of microRNAs in gastric cancer. World J Gastroenterol 2014; 20(19): 5694-5699 [PMID: 24914330 DOI: 10.3748/wjg.v20.i19.5694] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 68] [Article Influence: 7.9] [Reference Citation Analysis]
31 Su ZX, Zhao J, Rong ZH, Geng WM, Wu YG, Qin CK. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma. Diagn Pathol 2014;9:47. [PMID: 24593846 DOI: 10.1186/1746-1596-9-47] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
32 Wang L, Yao J, Shi X, Hu L, Li Z, Song T, Huang C. MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC Cancer 2013;13:448. [PMID: 24083596 DOI: 10.1186/1471-2407-13-448] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 8.2] [Reference Citation Analysis]
33 Zhang J, Xiao X, Ji L. Epigenetic disorder plays a fundamental role in the etiology of type 2 diabetes. Wuhan Univ J Nat Sci 2013;18:9-19. [DOI: 10.1007/s11859-013-0886-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
34 Kuo TY, Hsi E, Yang IP, Tsai PC, Wang JY, Juo SH. Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS One. 2012;7:e31587. [PMID: 22348113 DOI: 10.1371/journal.pone.0031587] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
35 Fassan M, Croce CM, Rugge M. miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol 2011; 17(48): 5231-5239 [PMID: 22219591 DOI: 10.3748/wjg.v17.i48.5231] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
36 Wang P, Xie S, Cui A, Zhang Y, Jiang B. miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects. Exp Ther Med 2012;3:324-30. [PMID: 22969890 DOI: 10.3892/etm.2011.399] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
37 Yu G, Tang JQ, Tian ML, Li H, Wang X, Wu T, Zhu J, Huang SJ, Wan YL. Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer. J Surg Oncol. 2012;106:232-237. [PMID: 22065543 DOI: 10.1002/jso.22138] [Cited by in Crossref: 60] [Cited by in F6Publishing: 72] [Article Influence: 5.5] [Reference Citation Analysis]
38 Anton R, Chatterjee SS, Simundza J, Cowin P, Dasgupta R. A systematic screen for micro-RNAs regulating the canonical Wnt pathway. PLoS One 2011;6:e26257. [PMID: 22043311 DOI: 10.1371/journal.pone.0026257] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
39 Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2010;11:537-561. [PMID: 21532838 DOI: 10.2174/138920210793175895] [Cited by in Crossref: 1008] [Cited by in F6Publishing: 1069] [Article Influence: 91.6] [Reference Citation Analysis]
40 Pekow JR, Dougherty U, Mustafi R, Zhu H, Kocherginsky M, Rubin DT, Hanauer SB, Hart J, Chang EB, Fichera A. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis. 2012;18:94-100. [PMID: 21557394 DOI: 10.1002/ibd.21742] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 8.1] [Reference Citation Analysis]
41 Pekow JR, Kwon JH. MicroRNAs in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:187-193. [PMID: 21425211 DOI: 10.1002/ibd.21691] [Cited by in Crossref: 105] [Cited by in F6Publishing: 116] [Article Influence: 9.5] [Reference Citation Analysis]
42 Liu L, Chen L, Xu Y, Li R, Du X. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun. 2010;400:236-240. [PMID: 20727858 DOI: 10.1016/j.bbrc.2010.08.046] [Cited by in Crossref: 159] [Cited by in F6Publishing: 156] [Article Influence: 13.3] [Reference Citation Analysis]
43 Zhang J, Zhang F, Didelot X, Bruce KD, Cagampang FR, Vatish M, Hanson M, Lehnert H, Ceriello A, Byrne CD. Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. BMC Genomics. 2009;10:478. [PMID: 19835573 DOI: 10.1186/1471-2164-10-478] [Cited by in Crossref: 148] [Cited by in F6Publishing: 158] [Article Influence: 11.4] [Reference Citation Analysis]
44 Shevde LA, Metge BJ, Mitra A, Xi Y, Ju J, King JA, Samant RS. Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin. J Cell Mol Med 2010;14:1693-706. [PMID: 19538464 DOI: 10.1111/j.1582-4934.2009.00821.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
45 Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T, Rogler CE. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol. 2008;173:856-864. [PMID: 18688024 DOI: 10.2353/ajpath.2008.080096] [Cited by in Crossref: 199] [Cited by in F6Publishing: 212] [Article Influence: 14.2] [Reference Citation Analysis]
46 Lee TM, Lipovich L. Structural differences of orthologous genes: insights from human-primate comparisons. Genomics 2008;92:134-43. [PMID: 18606524 DOI: 10.1016/j.ygeno.2008.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Ruike Y, Ichimura A, Tsuchiya S, Shimizu K, Kunimoto R, Okuno Y, Tsujimoto G. Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J Hum Genet 2008;53:515. [PMID: 18465083 DOI: 10.1007/s10038-008-0279-x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 4.9] [Reference Citation Analysis]
48 Huang JM, Ye J, Chen LB. Advances in research of microRNA- and HBV-related liver cancer. Shijie Huaren Xiaohua Zazhi 2008; 16(6): 645-652 [DOI: 10.11569/wcjd.v16.i6.645] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Shirina TV, Bobrovskaya MT, Kozlov EA. MicroRNA: from fundamental research to their application. Biopolym Cell 2007;23:467-482. [DOI: 10.7124/bc.000781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]